Savara
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
SVRA Key Statistics
Stock Snapshot
Savara(SVRA) stock is priced at $5.49, giving the company a market capitalization of 1.12B. It carries a P/E multiple of -10.26.
On 2026-03-05, Savara(SVRA) stock moved within a range of $5.43 to $5.66. With shares now at $5.49, the stock is trading +1.2% above its intraday low and -2.9% below the session's peak.
Trading volume for Savara(SVRA) stock has reached 1.26M, versus its average volume of 1.63M.
The stock's 52-week range extends from a low of $1.89 to a high of $7.01.
The stock's 52-week range extends from a low of $1.89 to a high of $7.01.
SVRA News
Savara Inc. recently announced that the FDA has accepted for review its Biologics License Application for MOLBREEVI to treat autoimmune pulmonary alveolar prote...
Savara (SVRA) is back in focus after the FDA accepted for review the biologics license application for MOLBREEVI to treat autoimmune pulmonary alveolar proteino...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.